These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1035 related items for PubMed ID: 15385112

  • 1. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS.
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [Abstract] [Full Text] [Related]

  • 2. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
    Kamelle SA, Rutledge TL, Tillmanns TD, Gould NS, Cohn DE, Wright J, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS.
    Gynecol Oncol; 2004 Aug; 94(2):249-55. PubMed ID: 15297159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
    Diaz JP, Sonoda Y, Leitao MM, Zivanovic O, Brown CL, Chi DS, Barakat RR, Abu-Rustum NR.
    Gynecol Oncol; 2008 Nov; 111(2):255-60. PubMed ID: 18755500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA, Covens A, Franssen E, Chapman W, Shaw P, Colgan T, Murphy J, DePetrillo D, Lickrish G, Laframboise S, Rosen B.
    Cancer; 2003 Apr 15; 97(8):1904-8. PubMed ID: 12673716
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A, Teti G, Barsotti C, Tana R, Fanucchi A, Orlandini C, Fabrini MG, Genazzani AR.
    Anticancer Res; 2010 Jan 15; 30(1):201-8. PubMed ID: 20150636
    [Abstract] [Full Text] [Related]

  • 10. Early cervical cancer and parametrial involvement: is it significant?
    Steed H, Capstick V, Schepansky A, Honore L, Hiltz M, Faught W.
    Gynecol Oncol; 2006 Oct 15; 103(1):53-7. PubMed ID: 16516279
    [Abstract] [Full Text] [Related]

  • 11. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.
    Gynecol Oncol; 2005 Mar 15; 96(3):651-7. PubMed ID: 15721407
    [Abstract] [Full Text] [Related]

  • 12. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis.
    Sevin BU, Lu Y, Bloch DA, Nadji M, Koechli OR, Averette HE.
    Cancer; 1996 Oct 01; 78(7):1438-46. PubMed ID: 8839549
    [Abstract] [Full Text] [Related]

  • 13. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
    Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, Rader JS, Mutch DG.
    Cancer; 2007 Sep 15; 110(6):1281-6. PubMed ID: 17654664
    [Abstract] [Full Text] [Related]

  • 14. Analysis of FIGO Stage IIIc endometrial cancer patients.
    McMeekin DS, Lashbrook D, Gold M, Johnson G, Walker JL, Mannel R.
    Gynecol Oncol; 2001 May 15; 81(2):273-8. PubMed ID: 11330962
    [Abstract] [Full Text] [Related]

  • 15. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.
    Schorge JO, Molpus KL, Koelliker D, Nikrui N, Goodman A, Fuller AF.
    Gynecol Oncol; 1997 Jul 15; 66(1):31-5. PubMed ID: 9234917
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extent of lymphovascular space invasion and risk of pelvic lymph node metastases in stage IB1 cervical cancer.
    Chandacham A, Charoenkwan K, Siriaunkgul S, Srisomboon J, Suprasert P, Phongnarisorn C, Cheewakraingkrai C, Siriaree S, Tantipalakorn C, Kietpeerakool C.
    J Med Assoc Thai; 2005 Oct 15; 88 Suppl 2():S31-6. PubMed ID: 17722314
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M, Graf AH, Lax S, Forstner R, Dandachi N, Haas J, Pickel H, Reich O, Staudach A, Winter R.
    Gynecol Oncol; 2001 Jul 15; 82(1):11-6. PubMed ID: 11426955
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.